Global Prefilled Syringes Market By Type (Disposable Prefilled Syringes, Reusable Prefilled Syringes), By Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2027
- Published date: Sep 2021
- Report ID: 45833
- Number of Pages: 267
- Format:
- keyboard_arrow_up
- 1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
2.0 Chapter 2
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.1.2 Opportunity Map Analysis
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Type
- 2.2.2 Market Snapshot, By Material
- 2.2.3 Market Snapshot, By Design
- 2.2.4 Market Snapshot, By Application
- 2.2.5 Market Snapshot, By Region
3.0 Chapter 3
- 3.1 Global Prefilled Syringes Market Dynamics
- 3.1.1 Drivers
- 3.1.2 Restrains
- 3.1.3 Opportunities
- 3.1.4 Trends
- 3.1.5 DR Impact Analysis
- 3.1.6 Prefilled Syringes Description
- 3.1.7 Regulatory Scenario
- 3.1.8 List of Product Recalls
- 3.1.9 Risk Analysis for Prefilled Syringes
- 3.1.10 Risk Management Process
- 3.1.11 PEST Analysis
- 3.1.12 Porter’s Five Forces Analysis
4.0 Chapter 4
- 4.0.1 Global Prefilled Syringes Market Analysis, by Type
- 4.0.2 Overview
- 4.0.3 Segment Trends
- 4.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
- 4.1 Disposable Prefilled Syringes
- 4.1.1 Overview
- 4.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 4.2 Reusable Prefilled Syringes
- 4.2.1 Overview
- 4.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
5.0 Chapter 5
- 5.0.1 Global Prefilled Syringes Market Analysis, by Material
- 5.0.2 Overview
- 5.0.3 Segment Trends
- 5.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 5.1 Plastic Prefilled Syringes
- 5.1.1 Overview
- 5.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 5.2 Glass Prefilled Syringes
- 5.2.1 Overview
- 5.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 5.2.3 Attributes of Glass Prefilled Syringes
6.0 Chapter 6
- 6.0.1 Global Prefilled Syringes Market Analysis, by Design
- 6.0.2 Overview
- 6.0.3 Segment Trends
- 6.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 6.1 Single-chamber
- 6.1.1 Overview
- 6.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 6.2 Dual-chamber
- 6.2.1 Overview
- 6.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
7.0 Chapter 7
- 7.0.1 Global Prefilled Syringes Market Analysis, by Application
- 7.0.2 Overview
- 7.0.3 Segment Trends
- 7.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 7.1 Anaphylaxis
- 7.1.1 Overview
- 7.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 7.2 Rheumatoid Arthritis
- 7.2.1 Overview
- 7.2.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 7.3 Diabetes
- 7.3.1 Overview
- 7.3.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 7.4 Others
- 7.4.1 Overview
- 7.4.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
8.0 Chapter 8
- 8.0.1 Global Prefilled Syringes Market Analysis, by Region
- 8.0.2 Overview
- 8.0.3 Market Attractiveness Index
- 8.0.4 Regional Trends
- 8.0.5 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 8.1 North America
- 8.1.1 Overview
- 8.1.2 Country Trends
- 8.1.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
- 8.1.4 US
- 8.1.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.1.5 Canada
- 8.1.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.2 Europe
- 8.2.1 Overview
- 8.2.2 Country Trends
- 8.2.3 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US$ Mn)
- 8.2.4 Germany
- 8.2.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.2.5 France
- 8.2.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.2.6 UK
- 8.2.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.2.7 Russia
- 8.2.7.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.2.8 Italy
- 8.2.8.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.3 Asia Pacific
- 8.3.1 Overview
- 8.3.2 Country Trends
- 8.3.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
- 8.3.4 China
- 8.3.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.3.5 Japan
- 8.3.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.3.6 South Korea
- 8.3.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.3.7 India
- 8.3.7.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.3.8 Southeast Asia
- 8.3.8.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.4 Latin America
- 8.4.1 Overview
- 8.4.2 Country Trends
- 8.4.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
- 8.4.4 Brazil
- 8.4.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.4.5 Mexico
- 8.4.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.4.6 Rest of Latin America
- 8.4.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.5 Middle East & Africa
- 8.5.1 Overview
- 8.5.2 Country Trends
- 8.5.3 Market Share and Forecast, and Y-o-Y Growth, 2016–2026, (US$ Mn)
- 8.5.4 GCC
- 8.5.4.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.5.5 Israel
- 8.5.5.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.5.6 South Africa
- 8.5.6.1 Market Value and Forecast, 2016–2026, (US$ Mn)
- 8.5.7 Rest of Middle East & Africa
- 8.5.7.1 Market Value and Forecast, 2016–2026, (US$ Mn)
9.0 Chapter 9
- 9.0.1 Company Profiles
- 9.0.1 Heat Map Analysis
- 9.1 Becton, Dickinson and Company
- 9.1.1 Company Overview
- 9.1.2 Product Portfolio
- 9.1.3 Financial Overview
- 9.1.4 Key Developments
- 9.1.5 SWOT Analysis
- 9.2 Gerresheimer AG
- 9.2.1 Company Overview
- 9.2.2 Product Portfolio
- 9.2.3 Financial Overview
- 9.2.4 Key Developments
- 9.2.5 SWOT Analysis
- 9.3 SCHOTT AG
- 9.3.1 Company Overview
- 9.3.2 Product Portfolio
- 9.3.3 Financial Overview
- 9.3.4 Key Developments
- 9.3.5 SWOT Analysis
- 9.4 West Pharmaceutical Services, Inc.
- 9.4.1 Company Overview
- 9.4.2 Product Portfolio
- 9.4.3 Financial Overview
- 9.4.4 Key Developments
- 9.4.5 SWOT Analysis
- 9.5 Stevanato Group S.p.a. (Ompi)
- 9.5.1 Company Overview
- 9.5.2 Product Portfolio
- 9.5.3 Financial Overview
- 9.5.4 Key Developments
- 9.5.5 SWOT Analysis
- 9.6 Catalent, Inc.
- 9.6.1 Company Overview
- 9.6.2 Product Portfolio
- 9.6.3 Financial Overview
- 9.6.4 Key Developments
- 9.6.5 SWOT Analysis
- 9.7 Weigao Group
- 9.7.1 Company Overview
- 9.7.2 Product Portfolio
- 9.7.3 Financial Overview
- 9.7.4 Key Developments
- 9.7.5 SWOT Analysis
- 9.8 Vetter Pharma-Fertigung GmbH & Co. KG
- 9.8.1 Company Overview
- 9.8.2 Product Portfolio
- 9.8.3 Financial Overview
- 9.8.4 Key Developments
- 9.8.5 SWOT Analysis
- 9.9 NIPRO PHARMA CORPORATION
- 9.9.1 Company Overview
- 9.9.2 Product Portfolio
- 9.9.3 Financial Overview
- 9.9.4 Key Developments
- 9.9.5 SWOT Analysis
- 9.10 MedPro Inc.
- 9.10.1 Company Overview
- 9.10.2 Product Portfolio
- 9.10.3 Financial Overview
- 9.10.4 Key Developments
- 9.10.5 SWOT Analysis
10.0 Chapter 10
- 10.1 Research Methodology
- 10.2 About Us
- 1.0 Chapter 1
- Becton, Dickinson and Company
- Gerresheimer AG Company Profile
- Schott AG Company Profile
- West Pharmaceutical Services, Inc. Company Profile
- Stevanato Group S.p.a. (Ompi)
- Catalent, Inc.
- Weigao Group
- Vetter Pharma-Fertigung GmbH & Co. KG
- NIPRO PHARMA CORPORATION
- MedPro Inc.
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |